Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Accepted/In press

Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prehabilitation in surgery - Need for new strategies?

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment

    Research output: Contribution to journalEditorialResearchpeer-review

  1. Immediate direct-to-implant breast reconstruction with acellular dermal matrix: Evaluation of complications and safety

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Treatment of osteoarthritis with autologous, micro-fragmented adipose tissue: a study protocol for a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. ESPRAS Survey on Breast Reconstruction in Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction: The use of routine imaging with 18F-FDG PET-CT (PET-CT) in melanoma surveillance is debated and evidence of its diagnostic value and yield in asymptomatic patients is limited. Denmark introduced nationwide routine surveillance with PET-CT in high-risk patients in 2016. The aim of this study was to examine the sensitivity, specificity, negative and positive predictive values, numbers-needed-to-scan and clinical impact of routine PET-CT in the surveillance of asymptomatic stage IIB-III melanoma patients. Materials and methods: Data was retrieved from the population-based Danish Melanoma Database and patient records. All patients diagnosed with stage IIB-III melanoma at two University Hospitals in 2016 and 2017 were included. Patients underwent surveillance with clinical examinations and PET-CT scans at 6, 12, 24 and 36 months. Results: In 138 patients, 243 routine PET-CTs were performed within a median follow-up time of 17.7 months. Routine PET-CT detected recurrence at least once in 25 patients (18.1%), including distant recurrence in 19 patients (13.8%). Stage IIB patients had the lowest recurrence rate (11.1%). Numbers-needed-to-scan to detect one distant recurrence was 12.8 patients and median time-to-recurrence was 6.8 months. Sensitivity was 100%, specificity was 94.7% and negative and positive predictive values were 100% and 74.4%, respectively. False positive findings prompted 22 additional investigations (of which ten invasive) in 17 patients (12.3%). Conclusion: Routine PET-CT has a high sensitivity and specificity when used in high-risk melanoma surveillance. Time-to-recurrence and stage-specific recurrence rates indicate high gain of early routine imaging at six months especially for stage IIC and III patients.

Original languageEnglish
JournalEuropean Journal of Surgical Oncology
ISSN0748-7983
DOIs
Publication statusAccepted/In press - 2021

    Research areas

  • 18F-FDG PET-CT, Asymptomatic recurrence, Melanoma, Routine imaging, Surveillance

ID: 66501486